Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: A single institute experience in Japan

A. Tomonari, S. Takahashi, J. Ooi, N. Tsukada, T. Konuma, T. Kobayashi, A. Sato, T. Iseki, T. Yamaguchi, A. Tojo, S. Asano

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

The impact of ABO incompatibility between donor and recipient on engraftment and transfusion requirement was studied in 95 adults who underwent unrelated cord blood transplantation (CBT). The patients included 27 ABO-identical, 29 minor, 21 major and 18 bidirectional ABO-incompatible recipients. Neutrophil engraftment did not differ between ABO-identical-minor ABO-incompatible and major-bidirectional ABO-incompatible recipients (hazard ratio (HR) 1.17, P = 0.48). Cumulative incidence of platelet engraftment in ABO-identical-minor ABO-incompatible recipients was higher than in major-bidirectional ABO-incompatible recipients (HR 1.88, P = 0.013). In addition, fewer platelet transfusions were required during the first 60 days after CBT in ABO-identical-minor ABO-incompatible recipients (HR 0.80, P = 0.040). RBC engraftment did not differ between the two groups (HR 1.25, P = 0.33). However, fewer RBC transfusions were required in ABO-identical-minor ABO-incompatible recipients than in major-bidirectional ABO-incompatible recipients (HR 0.74, P = 0.005). No patients developed pure red-cell aplasia after CBT. These results indicate that ABO incompatibility affected platelet engraftment and transfusion requirement of RBC and platelet in CBT recipients. Further studies including larger patient numbers are required to elucidate the impact of ABO incompatibility on the clinical outcome of CBT.

Original languageEnglish
Pages (from-to)523-528
Number of pages6
JournalBone Marrow Transplantation
Volume40
Issue number6
DOIs
Publication statusPublished - 2007 Sep
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint

Dive into the research topics of 'Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: A single institute experience in Japan'. Together they form a unique fingerprint.

Cite this